{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:58:45Z","timestamp":1782763125549,"version":"3.54.5"},"reference-count":76,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"funder":[{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z191100006619085"],"award-info":[{"award-number":["Z191100006619085"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Expert Rev. Mol. Med."],"published-print":{"date-parts":[[2024]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>In vitro fertilization (IVF) and embryo transfer and intracytoplasmic sperm injection (ICSI) have allowed millions of infertile couples to achieve pregnancy. As an essential part of IVF\/ICSI enabling the retrieval of a high number of oocytes in one cycle, controlled ovarian stimulation (COS) treatment mainly composes of the standard long gonadotrophin-releasing hormone agonist (GnRH-a) protocol and the gonadotrophin-releasing hormone antagonist (GnRH-ant) protocol. However, the effectiveness of GnRH-ant protocol is still debated because of inconsistent conclusions and insufficient subgroup analyses. This systematic review and meta-analysis included a total of 52 studies, encompassing 5193 participants in the GnRH-ant group and 4757 in the GnRH-a group. The findings of this study revealed that the GnRH-ant protocol is comparable with the long GnRH-a protocol when considering live birth as the primary outcome, and it is a favourable protocol with evidence reducing the incidence of ovarian hyperstimulation syndrome in women undergoing IVF\/ICSI, especially in women with polycystic ovary syndrome. Further research is needed to compare the subsequent cumulative live birth rate between the two protocols among the general and poor ovarian response patients since those patients have a lower clinical pregnancy rate, fewer oocytes retrieved or fewer high-grade embryos in the GnRH-ant protocol.<\/jats:p>","DOI":"10.1017\/erm.2023.25","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T09:56:13Z","timestamp":1702547773000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":15,"title":["Live birth rate of gonadotropin-releasing hormone antagonist versus luteal phase gonadotropin-releasing hormone agonist protocol in IVF\/ICSI: a systematic review and meta-analysis"],"prefix":"10.1017","volume":"26","author":[{"given":"Chenhong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7968-2240","authenticated-orcid":false,"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6381-5202","authenticated-orcid":false,"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"S146239942300025X_ref52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2012.09.008","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial","volume":"166","author":"Prapas","year":"2013","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"S146239942300025X_ref54","first-page":"1063","article-title":"Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol","volume":"17","author":"Rabati","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"key":"S146239942300025X_ref63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.17772\/gp\/62205","article-title":"Flexible GnRH antagonist protocol vs. long GnRH agonist protocol in patients with polycystic ovary syndrome treated for IVF: comparison of clinical outcome and embryo quality","volume":"87","author":"Trenkic","year":"2016","journal-title":"Ginekologia Polska"},{"key":"S146239942300025X_ref9","first-page":"450","article-title":"Treatment strategies for infertile women with polycystic ovary syndrome","volume":"68","author":"Vitek","year":"2016","journal-title":"Minerva Ginecologica"},{"key":"S146239942300025X_ref14","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"S146239942300025X_ref15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin","volume":"15","author":"Albano","year":"2000","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref11","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"5","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"S146239942300025X_ref65","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","article-title":"The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study","volume":"35","author":"Xu","year":"2020","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12958-016-0225-2","article-title":"Systematic review of worldwide trends in assisted reproductive technology 2004\u20132013","volume":"15","author":"Kushnir","year":"2017","journal-title":"Reproductive Biology and Endocrinology"},{"key":"S146239942300025X_ref27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","year":"2001","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1472-6483(10)60976-5","article-title":"Luteal phase characteristics following GnRH antagonist or agonist treatment \u2013 a comparative study","volume":"12","author":"Friedler","year":"2006","journal-title":"Reproductive Biomedicine Online"},{"key":"S146239942300025X_ref34","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3109\/09513590.2014.964638","article-title":"Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial","volume":"32","author":"Gizzo","year":"2014","journal-title":"Gynecological Endocrinology"},{"key":"S146239942300025X_ref49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12325-008-0028-8","article-title":"Comparison of GnRH agonists and antagonists in normoresponder IVF\/ICSI in Turkish female patients","volume":"25","author":"Moraloglu","year":"2008","journal-title":"Advances in Therapy"},{"key":"S146239942300025X_ref40","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/humrep\/del030","article-title":"Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF\/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study","volume":"21","author":"Huirne","year":"2006","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejogrb.2012.06.010","article-title":"Follicular fluid concentrations of IGF-I, IGF-II, IGFBP-3, VEGF, AMH, and inhibin-B in women undergoing controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist","volume":"164","author":"Kaya","year":"2012","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"S146239942300025X_ref53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3109\/09513590.2012.665103","article-title":"A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates","volume":"28","author":"Qiao","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"S146239942300025X_ref60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-010-1429-x","article-title":"Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOS patients","volume":"282","author":"Tehraninejad","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"S146239942300025X_ref59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00404-008-0620-9","article-title":"Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"278","author":"Tazegul","year":"2008","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"S146239942300025X_ref64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejogrb.2004.11.005","article-title":"A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy","volume":"120","author":"Xavier","year":"2005","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"key":"S146239942300025X_ref42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5653\/cerm.2011.38.4.228","article-title":"GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF\/ICSI","volume":"38","author":"Kim","year":"2011","journal-title":"Clinical and Experimental Reproductive Medicine"},{"key":"S146239942300025X_ref19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","article-title":"A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist\/rFSH in women with oral contraceptives before in vitro fertilization","volume":"83","author":"Barmat","year":"2005","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref50","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.fertnstert.2006.12.046","article-title":"GnRH agonist and antagonist protocols for stage I\u2013II endometriosis and endometrioma in in vitro fertilization\/intracytoplasmic sperm injection cycles","volume":"88","author":"Pabuccu","year":"2007","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref74","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/09513590.2019.1622086","article-title":"Luteal estradiol pretreatment of poor and normal responders during GnRH antagonist protocol","volume":"35","author":"Sefrioui","year":"2019","journal-title":"Gynecological Endocrinology"},{"key":"S146239942300025X_ref16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3109\/09513590.2014.929655","article-title":"Follicular fluid and serum vascular endothelial growth factor, interleukin (IL)-1 beta and glycodelin concentrations: comparison between long-gonadotropin-releasing hormone (GnRH)-agonist and GnRH-antagonist cycles: a randomized controlled trial","volume":"30","author":"Aydin","year":"2014","journal-title":"Gynecological Endocrinology"},{"key":"S146239942300025X_ref67","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Human Reproduction Update"},{"key":"S146239942300025X_ref28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejogrb.2005.08.017","article-title":"Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist\/FSH ovarian stimulation cycles","volume":"124","author":"Ferrari","year":"2006","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"S146239942300025X_ref43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5653\/cerm.2012.39.1.22","article-title":"Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"39","author":"Kim","year":"2012","journal-title":"Clinical and Experimental Reproductive Medicine"},{"key":"S146239942300025X_ref51","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/humrep\/des066","article-title":"GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study","volume":"27","author":"Papanikolaou","year":"2012","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5653\/cerm.2018.45.3.135","article-title":"Early gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome: a preliminary randomized trial","volume":"45","author":"Shin","year":"2018","journal-title":"Clinical and Experimental Reproductive Medicine"},{"key":"S146239942300025X_ref18","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study","volume":"50","author":"Bah\u00e7eci","year":"2005","journal-title":"Journal of Reproductive Medicine"},{"key":"S146239942300025X_ref17","first-page":"49","article-title":"Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis","volume":"10","author":"Badrawi","year":"2005","journal-title":"Middle East Fertility Society Journal"},{"key":"S146239942300025X_ref58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref73","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","article-title":"Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis","volume":"90","author":"Griesinger","year":"2008","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref75","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5468\/ogs.2018.61.1.102","article-title":"Efficacy of luteal estrogen administration and an early follicular gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization","volume":"61","author":"Lee","year":"2018","journal-title":"Obstetrics and Gynecology Science"},{"key":"S146239942300025X_ref25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-10-26","article-title":"GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF\/ET)","volume":"10","author":"Depalo","year":"2012","journal-title":"Reproductive Biology and Endocrinology"},{"key":"S146239942300025X_ref24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/09513590.2015.1092136","article-title":"Which is the best IVF\/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial","volume":"32","author":"Dakhly","year":"2016","journal-title":"Gynecological Endocrinology"},{"key":"S146239942300025X_ref20","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial","volume":"15","author":"Borm","year":"2000","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref48","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.fertnstert.2004.04.051","article-title":"A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol","volume":"82","author":"Loutradis","year":"2004","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref76","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","author":"Al-Inany","year":"2005","journal-title":"Reproductive Biomedicine Online"},{"key":"S146239942300025X_ref71","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/humrep\/dew325","article-title":"Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome","volume":"32","author":"Wei","year":"2017","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2014.12.021","article-title":"GnRH-antagonist programming versus GnRH agonist protocol: a randomized trial","volume":"185","author":"Hershko Klement","year":"2015","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"S146239942300025X_ref72","first-page":"CD006109","article-title":"Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques","volume":"5","author":"Farquhar","year":"2017","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"S146239942300025X_ref3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing-hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer \u2013 a metaanalysis of randomized controlled trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF. A systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Human Reproduction Update"},{"key":"S146239942300025X_ref66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10815-009-9300-3","article-title":"IVF\/ICSI outcomes between cycles with luteal estradiol (E-2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study","volume":"26","author":"Ye","year":"2009","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"S146239942300025X_ref68","doi-asserted-by":"crossref","first-page":"e0207081","DOI":"10.1371\/journal.pone.0207081","article-title":"GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: a retrospective study","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS ONE"},{"key":"S146239942300025X_ref56","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.fertnstert.2006.02.110","article-title":"Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial","volume":"86","author":"Serafini","year":"2006","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deh668","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial","volume":"20","author":"Cheung","year":"2005","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00404-009-1073-5","article-title":"Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART","volume":"281","author":"Firouzabadi","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"S146239942300025X_ref62","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Human Reproduction Update"},{"key":"S146239942300025X_ref69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fendo.2020.00192","article-title":"What is the best regimen for ovarian stimulation of poor responders in ART\/IVF?","volume":"11","author":"Blumenfeld","year":"2020","journal-title":"Frontiers in Endocrinology"},{"key":"S146239942300025X_ref12","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"S146239942300025X_ref37","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1210\/jc.2002-020788","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol","volume":"88","author":"Hohmann","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"S146239942300025X_ref38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","article-title":"Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients","volume":"36","author":"Hosseini","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"S146239942300025X_ref6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2004.01.033","article-title":"GnRH antagonists","volume":"115","author":"Coccia","year":"2004","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"S146239942300025X_ref46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.fertnstert.2011.06.022","article-title":"Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial","volume":"96","author":"Garcia-Velasco","year":"2011","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1477-7827-10-33","article-title":"GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology","volume":"10","author":"Cota","year":"2012","journal-title":"Reproductive Biology and Endocrinology"},{"key":"S146239942300025X_ref30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0015-0282(16)53348-2","article-title":"Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization \u2013 a European series and a proposal for prevention","volume":"53","author":"Forman","year":"1990","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref70","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(16)53282-8","article-title":"Gonadotropin suppression with oral-contraceptives before in vitro fertilization","volume":"53","author":"Gonen","year":"1990","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref26","doi-asserted-by":"crossref","first-page":"e47106","DOI":"10.1371\/journal.pone.0047106","article-title":"Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist","volume":"7","author":"Devjak","year":"2012","journal-title":"PLoS ONE"},{"key":"S146239942300025X_ref10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review","volume":"14","author":"Al-Inany","year":"2007","journal-title":"Reproductive Biomedicine Online"},{"key":"S146239942300025X_ref39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1028-4559(08)60057-1","article-title":"Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization","volume":"47","author":"Hsieh","year":"2008","journal-title":"Taiwanese Journal of Obstetrics and Gynecology"},{"key":"S146239942300025X_ref45","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","article-title":"Initiation of GnRH antagonist on day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development","volume":"22","author":"Lainas","year":"2007","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref61","first-page":"171","article-title":"GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran","volume":"9","author":"Tehraninejad","year":"2011","journal-title":"Iranian Journal of Reproductive Medicine"},{"key":"S146239942300025X_ref55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/dei302","article-title":"A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients","volume":"21","author":"Rombauts","year":"2006","journal-title":"Human Reproduction"},{"key":"S146239942300025X_ref47","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.fertnstert.2004.12.037","article-title":"Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration","volume":"83","author":"Lee","year":"2005","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1471-0528.1982.tb04642.x","article-title":"A new systematic treatment for infertile women with abnormal hormone profiles","volume":"89","author":"Fleming","year":"1982","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"S146239942300025X_ref8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-012-2348-9","article-title":"IVF\/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial","volume":"286","author":"Haydardedeoglu","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"S146239942300025X_ref44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10815-006-9036-2","article-title":"Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol","volume":"23","author":"Koichi","year":"2006","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"S146239942300025X_ref7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.fertnstert.2010.06.068","article-title":"Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis","volume":"95","author":"Bodri","year":"2011","journal-title":"Fertility and Sterility"},{"key":"S146239942300025X_ref21","first-page":"257","article-title":"Effect of antagonists vs agonists on in vitro fertilization outcome","volume":"31","author":"Check","year":"2004","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"key":"S146239942300025X_ref32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-020-00628-6","article-title":"Corifollitropin alfa for poor responders patients, a prospective randomized study","volume":"18","author":"Fusi","year":"2020","journal-title":"Reproductive Biology and Endocrinology"}],"container-title":["Expert Reviews in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S146239942300025X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T08:09:17Z","timestamp":1707811757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S146239942300025X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":76,"alternative-id":["S146239942300025X"],"URL":"https:\/\/doi.org\/10.1017\/erm.2023.25","relation":{},"ISSN":["1462-3994"],"issn-type":[{"value":"1462-3994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"Copyright \u00a9 Peking University Third Hospital, 2024. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is used to distribute the re-used or adapted article and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e2"}}